Search:
This item requires a subscription.
Training for anticoagulation management Thrombus, Volume 10, Number 2.
One of the frustrations of working within the area of thrombosis and haemostasis has been the lack of recognition of the importance of anticoagulation therapy. For example, a 68% reduction in the risk of stroke for patients with atrial fibrillation makes warfarin one of the most powerful therapeutic interventions we have.1 Despite this, and possibly because warfarin is not a patented drug, it is only recently that anticoagulation services have been taken seriously; for example, with their inclusion in the new Quality and Outcomes Framework for primary care.
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.